* Press release – first positive phase 3 results in adjuvant
setting for renal cell carcinoma show sutent (sunitinib)
extended disease free survival after surgical removal
The post BRIEF-Pfizer announces results from Phase 3 S-TRAC clinical trial appeared first on NASDAQ.